Insys Therapeutics, Inc. Revenue
Insys Therapeutics, Inc. reported Revenue of $57.77 million for the 3-month period ending 2016-09-30, per its 10-Q/A filed 2017-04-07.
Discontinued › Income Statement › Revenue
us-gaap:Revenues · last filed 2017-04-07
- Insys Therapeutics, Inc. revenues for the quarter ending 2016-09-30 was $57.77M, a 36.69% decline year-over-year.
- Insys Therapeutics, Inc. revenues for the quarter ending 2016-06-30 was $69.22M, a 13.69% decline year-over-year.
- Insys Therapeutics, Inc. revenues for the quarter ending 2016-03-31 was $60.42M, a 10.74% decline year-over-year.
- Insys Therapeutics, Inc. revenues for the quarter ending 2015-12-31 was $94.39M, a 41.91% increase year-over-year.
- Insys Therapeutics, Inc. revenues for fiscal 2015 was $330.80M, a 48.92% increase from fiscal 2014.
- Insys Therapeutics, Inc. revenues for fiscal 2014 was $222.13M, a 123.72% increase from fiscal 2013.
- Insys Therapeutics, Inc. revenues for fiscal 2013 was $99.29M, a 541.57% increase from fiscal 2012.
- Insys Therapeutics, Inc. revenues for fiscal 2012 was $15.48M.
| Period end | Revenues 3 month | Revenues 3 month as first filed | Revenues 6 month | Revenues 6 month as first filed | Revenues 9 month | Revenues 9 month as first filed | Revenues 12 month |
|---|---|---|---|---|---|---|---|
| 2016-09-30 | $57.77M 10-Q/A · filed 2017-04-07 | $55.18M 10-Q · filed 2016-11-03 | $126.99M derived: sum of 2 quarters · filed 2017-04-07 | $187.41M 10-Q/A · filed 2017-04-07 | $184.26M 10-Q · filed 2016-11-03 | $281.80M derived: sum of 4 quarters · filed 2017-04-07 | |
| 2016-06-30 | $69.22M 10-Q/A · filed 2017-04-07 | $67.12M 10-Q · filed 2016-08-05 | $129.64M 10-Q/A · filed 2017-04-07 | $129.08M 10-Q · filed 2016-08-05 | $224.03M derived: sum of 3 quarters · filed 2017-04-07 | $312.55M derived: sum of 4 quarters · filed 2017-04-07 | |
| 2016-03-31 | $60.42M 10-Q/A · filed 2017-04-07 | $61.96M 10-Q · filed 2016-05-05 | $154.81M derived: sum of 2 quarters · filed 2017-04-07 | $243.32M derived: sum of 3 quarters · filed 2017-04-07 | $323.52M derived: sum of 4 quarters · filed 2017-04-07 | ||
| 2015-12-31 | $94.39M derived: 10-K 12 month − 10-Q/A 9 month · filed 2016-02-29 | $182.90M derived: sum of 2 quarters · filed 2017-04-07 | $263.10M derived: sum of 3 quarters · filed 2017-04-07 | $330.80M 10-K · filed 2016-02-29 | |||
| 2015-09-30 | $91.26M 10-Q · filed 2016-11-03 | $168.72M derived: sum of 2 quarters · filed 2017-04-07 | $236.41M 10-Q/A · filed 2017-04-07 | $239.66M 10-Q · filed 2015-11-05 | $302.92M derived: sum of 4 quarters · filed 2017-04-07 | ||
| 2015-06-30 | $80.20M 10-Q/A · filed 2017-04-07 | $77.63M 10-Q · filed 2015-08-06 | $147.89M 10-Q/A · filed 2017-04-07 | $148.40M 10-Q · filed 2015-08-06 | $214.40M derived: sum of 3 quarters · filed 2017-04-07 | $272.69M derived: sum of 4 quarters · filed 2017-04-07 | |
| 2015-03-31 | $67.69M 10-Q/A · filed 2017-04-07 | $70.77M 10-Q · filed 2015-05-11 | $134.20M derived: sum of 2 quarters · filed 2017-04-07 | $192.49M derived: sum of 3 quarters · filed 2017-04-07 | $248.18M derived: sum of 4 quarters · filed 2017-04-07 | ||
| 2014-12-31 | $66.51M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $124.79M derived: sum of 2 quarters · filed 2016-02-29 | $180.49M derived: sum of 3 quarters · filed 2016-02-29 | $222.13M 10-K · filed 2016-02-29 | |||
| 2014-09-30 | $58.28M 10-Q · filed 2015-11-05 | $113.98M derived: sum of 2 quarters · filed 2015-11-05 | $155.61M 10-Q · filed 2015-11-05 | $195.81M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-06-30 | $55.70M 10-Q · filed 2015-08-06 | $97.33M 10-Q · filed 2015-08-06 | $137.53M derived: sum of 3 quarters · filed 2016-02-29 | $166.74M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-03-31 | $41.64M 10-Q · filed 2015-05-11 | $81.83M derived: sum of 2 quarters · filed 2016-02-29 | $111.05M derived: sum of 3 quarters · filed 2016-02-29 | $129.87M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2013-12-31 | $40.20M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $69.41M derived: sum of 2 quarters · filed 2016-02-29 | $88.23M derived: sum of 3 quarters · filed 2016-02-29 | $99.29M 10-K · filed 2016-02-29 | |||
| 2013-09-30 | $29.21M 10-Q · filed 2014-11-12 | $48.03M derived: sum of 2 quarters · filed 2014-11-12 | $59.09M 10-Q · filed 2014-11-12 | $64.25M derived: sum of 4 quarters · filed 2014-11-12 | |||
| 2013-06-30 | $18.82M 10-Q · filed 2014-08-12 | $29.88M 10-Q · filed 2014-08-12 | $35.04M derived: sum of 3 quarters · filed 2014-08-12 | $39.79M derived: sum of 4 quarters · filed 2014-08-12 | |||
| 2013-03-31 | $11.06M 10-Q · filed 2014-05-14 | $16.22M derived: sum of 2 quarters · filed 2014-05-14 | $20.97M derived: sum of 3 quarters · filed 2014-05-14 | $24.51M derived: sum of 4 quarters · filed 2014-05-14 | |||
| 2012-12-31 | $5.16M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-05 | $9.91M derived: sum of 2 quarters · filed 2014-03-05 | $13.45M derived: sum of 3 quarters · filed 2014-03-05 | $15.48M 10-K · filed 2014-03-05 | |||
| 2012-09-30 | $4.75M 10-Q · filed 2013-11-12 | $8.29M derived: sum of 2 quarters · filed 2013-11-12 | $10.32M 10-Q · filed 2013-11-12 | ||||
| 2012-06-30 | $3.54M 10-Q · filed 2013-08-13 | $5.57M 10-Q · filed 2013-08-13 | |||||
| 2012-03-31 | $2.03M 10-Q · filed 2013-06-05 |